- 日
- 関
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/05/02 01:20:05」(JST)
[Wiki en表示]
|
This article relies largely or entirely upon a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. (August 2014) |
Lomefloxacin
|
|
Systematic (IUPAC) name |
(RS)-1-Ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
|
Clinical data |
Trade names |
Maxaquin |
AHFS/Drugs.com |
Consumer Drug Information |
MedlinePlus |
a600002 |
Pharmacokinetic data |
Protein binding |
10% |
Biological half-life |
8 hours |
Identifiers |
CAS Number |
98079-51-7 Y |
ATC code |
J01MA07 (WHO) S01AE04 (WHO) |
PubChem |
CID 3948 |
DrugBank |
DB00978 Y |
ChemSpider |
3811 Y |
UNII |
9VC7S3ZXXB Y |
KEGG |
D02318 Y |
ChEBI |
CHEBI:116278 Y |
ChEMBL |
CHEMBL561 Y |
Chemical data |
Formula |
C17H19F2N3O3 |
Molar mass |
351.348 g/mol |
SMILES
-
Fc1c(c(F)c2c(c1)C(=O)C(\C(=O)O)=C/N2CC)N3CC(NCC3)C
|
InChI
-
InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25) Y
-
Key:ZEKZLJVOYLTDKK-UHFFFAOYSA-N Y
|
(verify) |
Lomefloxacin hydrochloride (sold under the following brand names in English speaking countries Maxaquin, Okacyn, Uniquin) is a fluoroquinolone antibiotic used to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. Lomefloxacin is associated with phototoxicity and central nervous system adverse effects.[1]
October 2008 the FDA added the following black box warning to the product insert for Maxaquin: Lomefloxacin is unique in that it forms a magnesium chelate with itself. The chelate is formed between the 2-carbonyl group of two separate lomefloxacin molecules.
See also
References
- ^ Rubinstein, E. (2001). "History of quinolones and their side effects.". Chemotherapy 47 (Suppl 3): 3–8; discussion 44–8. doi:10.1159/000057838. PMID 11549783.
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
DHFR inhibitor |
- 2,4-Diaminopyrimidine
- Trimethoprim#
- Brodimoprim
- Tetroxoprim
- Iclaprim†
|
|
Sulfonamides
(DHPS inhibitor) |
Short-
acting |
- Sulfaisodimidine
- Sulfamethizole
- Sulfadimidine
- Sulfapyridine
- Sulfafurazole
- Sulfanilamide
- Sulfathiazole
- Sulfathiourea
|
|
Intermediate-
acting |
- Sulfamethoxazole
- Sulfadiazine#
- Sulfamoxole
|
|
Long-
acting |
- Sulfadimethoxine
- Sulfadoxine
- Sulfalene
- Sulfametomidine
- Sulfametoxydiazine
- Sulfamethoxypyridazine
- Sulfaperin
- Sulfamerazine
- Sulfaphenazole
- Sulfamazone
|
|
Other/ungrouped |
- Sulfacetamide
- Sulfadicramide
- Sulfametrole
|
|
|
Combinations |
- Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
1st g. |
- Cinoxacin‡
- Flumequine‡
- Nalidixic acid‡
- Oxolinic acid‡
- Pipemidic acid‡
- Piromidic acid‡
- Rosoxacin‡
|
|
Fluoro-
quinolones |
2nd g. |
- Ciprofloxacin#
- Ofloxacin
- Enoxacin‡
- Fleroxacin‡
- Lomefloxacin‡
- Nadifloxacin‡
- Norfloxacin‡
- Pefloxacin‡
- Rufloxacin‡
|
|
3rd g. |
- Levofloxacin
- Balofloxacin‡
- Grepafloxacin‡
- Pazufloxacin‡
- Sparfloxacin‡
- Temafloxacin‡
- Tosufloxacin‡
|
|
4th g. |
- Besifloxacin
- Gatifloxacin
- Finafloxacin
- Gemifloxacin
- Moxifloxacin
- Clinafloxacin†
- Garenoxacin‡
- Prulifloxacin‡
- Sitafloxacin‡
- Trovafloxacin‡/Alatrofloxacin‡
|
|
Vet. |
- Danofloxacin
- Difloxacin
- Enrofloxacin
- Ibafloxacin
- Marbofloxacin
- Orbifloxacin
- Pradofloxacin
- Sarafloxacin
|
|
|
Newer non-fluorinated |
|
|
Related (DG) |
- Aminocoumarins: Novobiocin
|
|
|
Anaerobic DNA
inhibitors |
Nitro- imidazole derivatives |
- Metronidazole#
- Tinidazole
- Ornidazole
|
|
Nitrofuran derivatives |
- Nitrofurantoin#
- Furazolidone‡
- Nifurtoinol
|
|
|
RNA synthesis |
Rifamycins/
RNA polymerase |
- Rifampicin#
- Rifabutin
- Rifapentine
- Rifaximin
- Rifalazil§
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Interaction between holo transferrin and HSA-PPIX complex in the presence of lomefloxacin: An evaluation of PPIX aggregation in protein-protein interactions.
- Sattar Z, Iranfar H, Asoodeh A, Saberi MR, Mazhari M, Chamani J.SourceDepartment of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
- Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.Spectrochim Acta A Mol Biomol Spectrosc.2012 Nov;97:1089-100. doi: 10.1016/j.saa.2012.07.034. Epub 2012 Aug 4.
- Human serum albumin (HSA) and holo transferrin (TF) are two serum carrier proteins that are able to interact with each other, thereby altering their binding behavior toward their ligands. During the course of this study, the interaction between HSA-PPIX and TF, in the presence and absence of lomeflo
- PMID 22925987
- Determination of eight fluoroquinolones in groundwater samples with ultrasound-assisted ionic liquid dispersive liquid-liquid microextraction prior to high-performance liquid chromatography and fluorescence detection.
- Vázquez MM, Vázquez PP, Galera MM, García MD.SourceDepartment of Analytical Chemistry, University of Almería, La Cañada de San Urbano, 04120 Almería, Spain.
- Analytica chimica acta.Anal Chim Acta.2012 Oct 20;748:20-7. doi: 10.1016/j.aca.2012.08.042. Epub 2012 Aug 30.
- An ultrasound-assisted ionic liquid dispersive liquid-liquid microextraction (US-IL-DLLME) procedure was developed for the extraction of eight fluoroquinolones (marbofloxacin, norfloxacin, ciprofloxacin, lomefloxacin, danofloxacin, enrofloxacin, oxolinic acid and nalidixic acid) in groundwater, usin
- PMID 23021803
Japanese Journal
- Efficacy and safety of lomefloxacin on bacterial extraocular disease in the horse
- , , ,
- Journal of Veterinary Medical Science advpub(0), 2015
- … Lomefloxacin is a broad-spectrum fluoroquinolone antibiotic used for the treatment of bacterial extraocular disease. … This study investigated the efficacy and safety of lomefloxacin eye drops for bacterial extraocular disease in horses. … Lomefloxacin ophthalmic solution (0.3%) was instilled three times daily for 2–5 days in 65 horses diagnosed with bacterial extraocular disease based on clinical findings. … The efficacy of lomefloxacin was evaluated in 63 horses; …
- NAID 130004781129
- 犬の細菌性外耳炎に対する0.3%ロメフロキサシン眼科耳科用液の治療効果
- 高島 一昭,仲庭 茂樹,山根 義久
- 動物臨床医学 = Journal of Animal Clinical Research Foundation 22(3), 096-100, 2013-09-20
- NAID 10031201070
- 特集 新効能動物用抗菌性物質製剤 ロメフロキサシン(効能追加)
Related Links
- Lomefloxacin [LFLX] ロメフロキサシン, 合成抗菌剤(新キノロン系) 1. 商品名 先発品 ロメバクトカプセル100mg 【塩野義製薬】 バレオンカプセル100mg/バレオン錠200mg 【アボット ジャパン】 2. 日本における発売年 1990(平成2)年 ...
- [Lomefloxacin Hydrochloride] [98079-52-8] | 価格や在庫、物性値などの詳細情報ページです。 ... 別名 (英名) 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Hydrochloride 和名 塩酸 ...
Related Pictures
★リンクテーブル★
[★]
- 英
- lomefloxacin
- 化
- 塩酸ロメフロキサシン lomefloxacin hydrochloride
- 商
- バレオン、ロメバクト、ロメフロン、ロメフロンミニムス
- 関
- 眼科用剤。抗菌薬
[★]
- 関
- lomefloxacin